drugset / Trial / NCT00217659

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

NCT00217659

Open-labelTreatment

Summary

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using goserelin and anastrozole may fight breast cancer by blocking the use of estrogen by the tumor cells. Giving goserelin together with anastrozole may be an effective treatment for male breast cancer. PURPOSE: This phase II trial is studying how well giving goserelin together with anastrozole works in treating men with recurrent or metastatic breast cancer.

Timeline

Start
2005-09
Primary completion
2007-01
Completion
2007-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Anastrozole Other / unclassified Oral
Subject Goserelin Other / unclassified Subcutaneous

Indications